US Drug Recall Register

Is Chloride recalled?

Yes — there is an active recall. 326 ongoing FDA recalls mention Chloride (1,994 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chloride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class III · Low risk Terminated

Matzim LA

Reason GMP Deviation: lot not intended for commercial distribution.

Teva Pharmaceuticals USA NDC 52544-692-30 D-0131-2020
Class I · High risk Terminated

Quinacrine Dihydrochloride

Reason Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.

Darmerica, LLC NDC 71052-530-05 D-0125-2020
Class III · Low risk Terminated

minolira

Reason Failed Dissolution Specifications:

EPI Health, LLC NDC 71403-102-05 D-0120-2020
Class II · Moderate risk Terminated

Allergy

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 53943-021-09 D-1874-2019
Class II · Moderate risk Terminated

Wal-Fex

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 0363-0097-55 D-1873-2019
Class II · Moderate risk Terminated

Allergy

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 58602-820-09 D-1872-2019
Class II · Moderate risk Terminated

Fexofenadine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 62011-0315-1 D-1870-2019
Class II · Moderate risk Terminated

Fexofenadine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 70677-0008-2 D-1868-2019
Class II · Moderate risk Terminated

fexofenadine hydrochloride tablets USP

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 68196-976-91 D-1867-2019
Class III · Low risk Terminated

Pramipexole Dihydrochloride Tablets 0.125 mg

Reason Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg

Macleods Pharma Usa Inc NDC 33342-031-10 D-1851-2019
Class II · Moderate risk Terminated

S-Manganese Chloride 0.1mg/Ml Mdv Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0239-2020
Class II · Moderate risk Terminated

S-Magnesium Chloride 200mg/Ml Mdv Inj

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0237-2020
Class II · Moderate risk Terminated

S-Calcium Chloride 100mg/Ml

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0206-2020
Class II · Moderate risk Terminated

S-Benzalkonium Chloride 0.013% Solution

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0205-2020
Class II · Moderate risk Terminated

Clear Eyes Redness Relief Hand Pocket Pal Tray Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1835-2019
Class II · Moderate risk Terminated

Clear eyes REDNESS RELIEF

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1834-2019
Class II · Moderate risk Terminated

Clear Eyes Redness Relief Handy Pocket Pal Club Pak Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1833-2019
Class II · Moderate risk Terminated

Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1832-2019
Class II · Moderate risk Terminated

Clear Eyes Maximum Redness Relief Club Pack Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1831-2019
Class II · Moderate risk Terminated

Clear Eyes Maximum Itchy Eye Relief Sidekick Floor Stand Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1830-2019
Class II · Moderate risk Terminated

Clear Eyes Redness Relief Club Pack Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1829-2019
Class II · Moderate risk Terminated

Clear Eyes Assorted Sidekick Floor Stand Display

Reason CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.

Medtech Products, Inc. D-1828-2019